Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tsukasa Murata"'
Autor:
Junji Saruwatari, Tetsuya Kaneko, Tsukasa Murata, Haruka Narise, Sawa Kugimoto, Eri Nishimura, Natsuki Tetsuka, Misaki Ando, Momo Oi, Masako Ota, Nayumi Hamada, Keiichiro Kaneda, Shiro Furusho, Masakatsu Sakamoto, Ayami Kajiwara‐Morita, Kazutaka Oda, Kentaro Oniki, Keishi Ueda, Hirofumi Jono, Norio Yasui‐Furukori
Publikováno v:
Neuropsychopharmacology Reports, Vol 44, Iss 3, Pp 614-619 (2024)
Abstract Aim Yokukansan is one of the most frequently used herbal medicines that can improve the behavioral and psychological symptoms of dementia. In this exploratory study, we investigated whether yokukansan affects the steady‐state blood concent
Externí odkaz:
https://doaj.org/article/386f5c7aa74645a3abe2bcb297fffb71
Publikováno v:
American Journal of Therapeutics; Jul/Aug2024, Vol. 31 Issue 4, p498-502, 5p
Publikováno v:
American Journal of Therapeutics; Jul/Aug2024, Vol. 31 Issue 4, p440-444, 5p
Autor:
Tsukasa Murata, Yoshitaka Nobukuni
Publikováno v:
American Journal of Therapeutics. 30:e261-e265
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::129e094625af96d1a261385596a02544
https://doi.org/10.1097/mjt.0000000000001549
https://doi.org/10.1097/mjt.0000000000001549
Autor:
Tsukasa Murata, Mayumi Hamada
Publikováno v:
International journal of clinical pharmacology and therapeutics. 60(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cacf5af822e34afb7d44842e14a7388
https://pubmed.ncbi.nlm.nih.gov/35924641
https://pubmed.ncbi.nlm.nih.gov/35924641
Autor:
Tsukasa Murata
Publikováno v:
Int. Journal of Clinical Pharmacology and Therapeutics. 59:341-342
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d48c64c518155932091d119fc138a34
https://doi.org/10.5414/cp203874
https://doi.org/10.5414/cp203874
Autor:
Tsukasa Murata, Yoshitaka Nobukuni
Publikováno v:
Clinical Neuropsychopharmacology and Therapeutics. 11:45-46
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f616082641489ce0198d217cbf41396f
https://doi.org/10.5234/cnpt.11.45
https://doi.org/10.5234/cnpt.11.45
Autor:
Tsukasa Murata, Chisato Takaishi, Masaharu Hori, Rie Nagata, Kazuko Nakagawa, Takayuki Seo, Takateru Ishitsu
Publikováno v:
Pharmacogenomics. 9:527-537
Background: Clobazam-induced adverse reactions have been reported in cases with CYP2C19 defective allele(s). However, the relevance of the CYP2C19 genotypes to clobazam therapy remains to be clarified. Methods: The association between CYP2C19 genotyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0af1afcd25a9c336d19a83144170b61
https://doi.org/10.2217/14622416.9.5.527
https://doi.org/10.2217/14622416.9.5.527
Autor:
Masaharu Hori, Takayuki Seo, Tsukasa Murata, Takateru Ishitsu, Nao Ueda, Kazuko Nakagawa, Kentaro Ueda
Publikováno v:
Pharmacogenomics. 8:435-442
The aim of this study is to verify whether the combination of glutathione S-transferase (GST) M1 null and GSTT1 null genotypes, which is a candidate genetic risk factor for troglitazone-induced liver failure, is common to that for the carbamazepine-i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1393588fa78872ac0a844bb4ba4cfe3
https://doi.org/10.2217/14622416.8.5.435
https://doi.org/10.2217/14622416.8.5.435
Autor:
Nao Ueda, Takayuki Seo, Tsukasa Murata, Naoyuki Nakada, Kazuko Nakagawa, Shuji Goto, Takateru Ishitsu
Publikováno v:
Therapeutic Drug Monitoring. 29:118-121
A nonlinear mixed-effect modeling (NONMEM) program was used to evaluate the effects of cytochrome P450 (CYP) 2C9 and CYP2C19 polymorphisms on the phenobarbital (PB) population clearance for Japanese epileptics. The pharmacokinetics of the 260 PB conc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8940504db256dc38abe0954da6d17df5
https://doi.org/10.1097/ftd.0b013e318030def0
https://doi.org/10.1097/ftd.0b013e318030def0